FORTRESS BIOTECH INC's ticker is FBIO and the CUSIP is 34960Q109. A total of 59 filers reported holding FORTRESS BIOTECH INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $2,867,000 | -22.3% | 603,657 | -39.4% | 0.36% | -23.1% |
| Q1 2017 | $3,688,000 | +13.8% | 996,663 | -17.0% | 0.47% | -28.1% |
| Q4 2016 | $3,241,000 | -19.6% | 1,200,342 | -11.5% | 0.66% | -7.4% |
| Q3 2016 | $4,029,000 | +12.9% | 1,356,636 | +2.3% | 0.71% | -10.8% |
| Q2 2016 | $3,569,000 | -13.9% | 1,326,636 | -0.8% | 0.79% | -45.2% |
| Q1 2016 | $4,147,000 | +11.1% | 1,337,869 | 0.0% | 1.45% | +12.5% |
| Q4 2015 | $3,733,000 | +12.6% | 1,337,869 | +4.9% | 1.29% | +49.2% |
| Q3 2015 | $3,316,000 | +6.2% | 1,275,521 | +37.2% | 0.86% | +0.2% |
| Q2 2015 | $3,123,000 | – | 929,531 | – | 0.86% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 3,750,000 | $12,075,000 | 2.26% |
| Nantahala Capital Management | 8,140,794 | $26,213,000 | 0.83% |
| SHIKIAR ASSET MANAGEMENT INC | 694,500 | $2,236,000 | 0.63% |
| PERKINS CAPITAL MANAGEMENT INC | 128,805 | $415,000 | 0.26% |
| Telemetry Investments, L.L.C. | 55,000 | $177,000 | 0.24% |
| CPWM, LLC | 514,767 | $1,658,000 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 187,178 | $603,000 | 0.06% |
| Spotlight Asset Group, Inc. | 10,700 | $34,000 | 0.02% |
| Summit Global Investments | 44,900 | $145,000 | 0.01% |
| Virtu Financial LLC | 25,714 | $83,000 | 0.01% |